Free Trial
NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

Shuttle Pharmaceuticals logo
$0.87 -0.03 (-2.97%)
(As of 02:20 PM ET)

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Key Stats

Today's Range
$0.85
$0.90
50-Day Range
$0.89
$1.87
52-Week Range
$0.83
$4.95
Volume
38,765 shs
Average Volume
461,731 shs
Market Capitalization
$3.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.

Shuttle Pharmaceuticals Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
11th Percentile Overall Score

SHPH MarketRank™: 

Shuttle Pharmaceuticals scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Shuttle Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Shuttle Pharmaceuticals is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Shuttle Pharmaceuticals is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    34.78% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently increased by 1,984.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Shuttle Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Shuttle Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    34.78% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently increased by 1,984.87%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Shuttle Pharmaceuticals has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Shuttle Pharmaceuticals this week, compared to 0 articles on an average week.
  • Search Interest

    4 people have searched for SHPH on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Shuttle Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Shuttle Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.60% of the stock of Shuttle Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.58% of the stock of Shuttle Pharmaceuticals is held by institutions.

  • Read more about Shuttle Pharmaceuticals' insider trading history.
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPH Stock News Headlines

Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
Micro Cap Company Is Soaring On Phase 2 Trial Update
See More Headlines

SHPH Stock Analysis - Frequently Asked Questions

Shuttle Pharmaceuticals' stock was trading at $1.96 on January 1st, 2024. Since then, SHPH stock has decreased by 55.5% and is now trading at $0.8713.
View the best growth stocks for 2024 here
.

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) posted its quarterly earnings results on Tuesday, September, 3rd. The company reported ($0.96) earnings per share for the quarter.

Shuttle Pharmaceuticals (SHPH) raised $10 million in an initial public offering on Wednesday, August 31st 2022. The company issued 1,225,888 shares at a price of $8.13 per share.

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shuttle Pharmaceuticals investors own include Mullen Automotive (MULN), MSP Recovery (LIFW), MSP Recovery (LIFW), NIO (NIO), Tesla (TSLA), Broadcom (AVGO) and AMTD Digital (HKD).

Company Calendar

Last Earnings
9/03/2024
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SHPH
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
$-6,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.36) per share

Miscellaneous

Free Float
2,214,000
Market Cap
$3.29 million
Optionable
Not Optionable
Beta
-1.32
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:SHPH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners